POLICY OPTIONS
FOR ASSURING AFFORDABLE ACCESS TO ESSENTIAL MEDICINES
The Bellagio Series on Development and Intellectual Property
Policy
At the
Rockefeller Foundation's Bellagio Study and Conference Center
on Lake Como in Northern Italy,
12 - 16 October 2004
Description
|
Programme
|
Participants
|
Documentation
Documents
Meeting
Report: Bellagio Dialogue on Ensuring Policy Options for Affordable
Access to Essential Medicines, Bellagio, Italy 12 to 16
October 2004.
Conclusions
of the Dialogue: Bellagio Dialogue on Ensuring Policy Options
for Affordable Access to Essential Medicines, Bellagio,
Italy 12 to 16 October 2004.
The
cycle of action and reaction: Latest developments and trends in
IP and health by Frederick ABBOTT, Florida
State University.
Intellectual
property and pharmaceutical data exclusivity in the context of
innovation and market access by Meir Perez PUGATCH,
University of Haifa.
Product
development partnerships on ‘neglected diseases’: How
they handle intellectual property and how this may contribute
to improving access to pharmaceuticals for HIV/AIDS, TB and Malaria
by Roy WIDDUS, Global Forum for Health Research.
Creating
And Promoting Domestic Drug Manufacturing Capacities: Legal And
Economic Feasibility Assessment by Juan ROVIRA,
University of Barcelona, Spain and SOIKOS.
Role,
Perspectives and Challenges of the Generic Pharmaceutical Industry
in Latin America by Mirta LEVIS, Centro Industrial
de Laboratorios Farmaceutícos Argentinos.
Advancing
public health by other means: Using competition policy to increase
access to essential medicines by Jonathan BERGER,
University of the Witwatersrand.
Market
Concentration Of The Transnational Pharmaceutical Industry And
The Generic Industries In The World: Latest Trends on Mergers,
Acquisitions and Other Transactions by Barbara
ROSENBERG, Ministry of Justice, Brazil.
